135 related articles for article (PubMed ID: 10465672)
1. Endothelin-secreting tumors and the idea of the pseudoectopic hormone secretion in tumors.
Kurbel S; Kurbel B; Kovacić D; Sulava D; Krajina Z; Dmitrović B; Sokcević M
Med Hypotheses; 1999 Apr; 52(4):329-33. PubMed ID: 10465672
[TBL] [Abstract][Full Text] [Related]
2. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Bishop JA; Sharma R; Illei PB
Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
[TBL] [Abstract][Full Text] [Related]
3. Endothelin in ectopic ACTH-secreting bronchial carcinoid tumors.
Takahashi K; Satoh F; Murakami O; Totsune K; Sone M; Itoi K; Ohneda M; Mouri T
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S288-90. PubMed ID: 7509967
[TBL] [Abstract][Full Text] [Related]
4. Expression of endothelins and their receptors promotes an invasive phenotype of breast tumor cells but is insufficient to induce invasion in benign cells.
Hagemann T; Binder C; Binder L; Pukrop T; Trümper L; Grimshaw MJ
DNA Cell Biol; 2005 Nov; 24(11):766-76. PubMed ID: 16274297
[TBL] [Abstract][Full Text] [Related]
5. Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors.
Pivonello R; Ferone D; de Herder WW; de Krijger RR; Waaijers M; Mooij DM; van Koetsveld PM; Barreca A; De Caro ML; Lombardi G; Colao A; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2004 Sep; 89(9):4493-502. PubMed ID: 15356054
[TBL] [Abstract][Full Text] [Related]
6. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1, Endothelin-A- and Endothelin-B-receptor expression in preinvasive and invasive breast disease.
Wülfing P; Diallo R; Kersting C; Wülfing C; Poremba C; Greb RR; Böcker W; Kiesel L
Oncol Rep; 2004 Apr; 11(4):791-6. PubMed ID: 15010874
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
9. A large amount of endothelin-1 is present in human breast cancer tissues.
Yamashita J; Ogawa M; Inada K; Yamashita S; Matsuo S; Takano S
Res Commun Chem Pathol Pharmacol; 1991 Dec; 74(3):363-9. PubMed ID: 1775726
[TBL] [Abstract][Full Text] [Related]
10. Production and secretion of two vasoactive peptides, adrenomedullin and endothelin-1, by cultured human adrenocortical carcinoma cells.
Takahashi K; Yoshinoya A; Murakami O; Totsune K; Shibahara S
Peptides; 2000 Feb; 21(2):251-6. PubMed ID: 10764953
[TBL] [Abstract][Full Text] [Related]
11. Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma.
Alanen K; Deng DX; Chakrabarti S
Histopathology; 2000 Feb; 36(2):161-7. PubMed ID: 10672062
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 stimulates aldosterone synthesis in Conn's adenomas via both A and B receptors coupled with the protein kinase C- and cyclooxygenase-dependent signaling pathways.
Rossi GP; Andreis PG; Neri G; Tortorella C; Pelizzo MR; Sacchetto A; Nussdorfer GG
J Investig Med; 2000 Sep; 48(5):343-50. PubMed ID: 10979239
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor.
Pflug BR; Zheng H; Udan MS; D'Antonio JM; Marshall FF; Brooks JD; Nelson JB
Cancer Lett; 2007 Feb; 246(1-2):139-48. PubMed ID: 16581180
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Secretion of endothelin-1 and adrenomedullin by SW-13 human adrenocortical carcinoma cells.
Takahashi K; Yoshinoya A; Murakami O; Totsune K; Shibahara S
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S393-4. PubMed ID: 11078430
[TBL] [Abstract][Full Text] [Related]
17. Targeting the endothelin system: novel therapeutic options in gynecological, urological and breast cancers.
Smollich M; Wülfing P
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1481-93. PubMed ID: 18759699
[TBL] [Abstract][Full Text] [Related]
18. Stimulation or endothelin-1 secretion by human breast cancer cells through protein kinase A activation: a possible novel paracrine loop involving breast fibroblast-derived prostaglandin E2.
Patel KV; Sheth HG; Schrey MP
Mol Cell Endocrinol; 1997 Feb; 126(2):143-51. PubMed ID: 9089652
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
